184 related articles for article (PubMed ID: 29753133)
1. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
[TBL] [Abstract][Full Text] [Related]
2. Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli.
Ho PL; Ng KY; Lo WU; Law PY; Lai EL; Wang Y; Chow KH
Antimicrob Agents Chemother; 2016 Jan; 60(1):537-43. PubMed ID: 26552976
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2.
García V; Montero I; Bances M; Rodicio R; Rodicio MR
Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653
[TBL] [Abstract][Full Text] [Related]
4. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and mechanism of triclosan resistance in Escherichia coli isolated from urine samples in Wenzhou, China.
Zeng W; Xu W; Xu Y; Liao W; Zhao Y; Zheng X; Xu C; Zhou T; Cao J
Antimicrob Resist Infect Control; 2020 Oct; 9(1):161. PubMed ID: 33008474
[TBL] [Abstract][Full Text] [Related]
6. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology and nitrofurantoin resistance determinants of nitrofurantoin-non-susceptible Escherichia coli isolated from urinary tract infections.
Mottaghizadeh F; Mohajjel Shoja H; Haeili M; Darban-Sarokhalil D
J Glob Antimicrob Resist; 2020 Jun; 21():335-339. PubMed ID: 31627025
[TBL] [Abstract][Full Text] [Related]
8. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.
Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT
Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485
[TBL] [Abstract][Full Text] [Related]
9. Alterations in chromosomal genes
Wan Y; Mills E; Leung RCY; Vieira A; Zhi X; Croucher NJ; Woodford N; Jauneikaite E; Ellington MJ; Sriskandan S
Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34860151
[TBL] [Abstract][Full Text] [Related]
10. Detection of floR gene and active efflux mechanism of Escherichia coli in Ningxia, China.
Wang YH; Li XN; Chen C; Zhang J; Wang GQ
Microb Pathog; 2018 Apr; 117():310-314. PubMed ID: 29481973
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
[TBL] [Abstract][Full Text] [Related]
12. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
[TBL] [Abstract][Full Text] [Related]
13. Development and analysis of furazolidone-resistant Escherichia coli mutants.
Martínez-Puchol S; Gomes C; Pons MJ; Ruiz-Roldán L; Torrents de la Peña A; Ochoa TJ; Ruiz J
APMIS; 2015 Aug; 123(8):676-81. PubMed ID: 26011027
[TBL] [Abstract][Full Text] [Related]
14. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
[TBL] [Abstract][Full Text] [Related]
16. Prediction of nitrofurantoin resistance among Enterobacteriaceae and mutational landscape of in vitro selected resistant Escherichia coli.
Khamari B; Adak S; Chanakya PP; Lama M; Peketi ASK; Gurung SA; Chettri S; Kumar P; Bulagonda EP
Res Microbiol; 2022; 173(1-2):103889. PubMed ID: 34718096
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of avian-origin mcr-1-positive Escherichia coli with a potential risk to humans in Tai'an, China.
Li X; Li L; Yu L; Liu S; Liu L; Wei X; Song Y; Liu C; Jiang M; Wang F
Poult Sci; 2020 Oct; 99(10):5118-5126. PubMed ID: 32988550
[TBL] [Abstract][Full Text] [Related]
18. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
Shin JH; Jung HJ; Lee JY; Kim HR; Lee JN; Chang CL
Microb Drug Resist; 2008 Sep; 14(3):221-6. PubMed ID: 18707554
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis.
Srinivasan V; Gillespie BE; Lewis MJ; Nguyen LT; Headrick SI; Schukken YH; Oliver SP
Vet Microbiol; 2007 Oct; 124(3-4):319-28. PubMed ID: 17544234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
